Mefoxin and Protonix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mefoxin (cefoxitin sodium) and Protonix (pantoprazole sodium). Common drug interactions include tricuspid valve incompetence among females and alanine aminotransferase decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Mefoxin and Protonix. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Mefoxin?

Mefoxin has active ingredients of cefoxitin sodium. eHealthMe is studying from 280 Mefoxin users. Check the latest studies of Mefoxin.

What is Protonix?

Protonix has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 132,659 Protonix users. Check the latest studies of Protonix.



On Aug, 01, 2026

32 people who take Mefoxin and Protonix together, and have interactions are studied.

Mefoxin and Protonix drug interactions.

What are the common drug interactions of Mefoxin and Protonix, by gender? *:

female:

  1. Tricuspid valve incompetence (inefficient heart valve)
  2. Tympanic membrane disorder (disease of ear drum)
  3. Uterine leiomyoma (uterine benign tumour derived from smooth muscle)
  4. Vasculitis (inflammation of a blood vessel or blood vessels)
  5. Vitreous detachment (a condition of the eye in which the vitreous humour separates from the retina)
  6. Wegener's granulomatosis (inflammation of the blood vessels lungs sinuses)
  7. Wound infection staphylococcal
  8. Osteonecrosis of jaw (death of bone of jaw)
  9. Abdominal pain
  10. Anaemia (lack of blood)

male:

  1. Alanine aminotransferase decreased
  2. Anion gap increased
  3. Blood magnesium decreased
  4. Blood phosphorus decreased
  5. Blood potassium decreased
  6. Blood sodium decreased
  7. Blood uric acid increased
  8. Burkitt's lymphoma stage ii (blood cancer stage ii)
  9. Carbon dioxide decreased
  10. Chapped lips (cracking, fissuring, and peeling of the skin f lip)

What are the common drug interactions of Mefoxin and Protonix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Alanine aminotransferase decreased
  2. Anion gap increased
  3. Ascites (accumulation of fluid in the abdominal cavity)
  4. Aspartate aminotransferase increased
  5. Atelectasis (partial or complete collapse of the lung)
  6. Blood albumin decreased
  7. Blood alkaline phosphatase decreased
  8. Blood calcium decreased
  9. Blood chloride decreased
  10. Blood glucose increased

20-29:

  1. Cholecystitis (infection of gallbladder)
  2. Emotional distress
  3. Injury
  4. Renal failure acute (rapid kidney dysfunction)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

30-39:

  1. Activated partial thromboplastin time prolonged
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Blood fibrinogen increased
  4. Blood triglycerides increased
  5. Chest pain
  6. Cholecystitis chronic (long lasting infection of gallbladder)
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Confusional state
  9. Cough
  10. Diarrhoea

40-49:

n/a

50-59:

  1. Hyperglycaemia (high blood sugar)
  2. Otitis externa (external ear infection)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Sensory loss (senses loss)
  5. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  6. Foot deformity (functional disability of foot)
  7. Rectal haemorrhage (bleeding from anus)
  8. Appendicitis (inflammation of the appendix)
  9. Aptyalism (deficiency or absence of saliva)
  10. Asthma

60+:

  1. Abdominal infection
  2. Enterocutaneous fistula
  3. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  4. Metastatic lymphoma (spreadable cancer tumour of lymph node)
  5. Pancreatitis acute (sudden inflammation of pancreas)
  6. Pancreatitis relapsing
  7. Psychotic disorder
  8. Hypoxia (low oxygen in tissues)
  9. Leukocytosis (increased white blood cells)
  10. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

What are the existing conditions these people have? *

  1. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 22 people, 68.75%
  2. Osteoporosis (bones weak and more likely to break): 22 people, 68.75%
  3. Thrombocytopenia (decrease of platelets in blood): 11 people, 34.38%
  4. Pain: 3 people, 9.38%
  5. Depression: 3 people, 9.38%
  6. Nausea (feeling of having an urge to vomit): 3 people, 9.38%
  7. Type 2 Diabetes: 2 people, 6.25%
  8. High Blood Pressure: 2 people, 6.25%
  9. Constipation: 2 people, 6.25%
  10. Dehydration (dryness resulting from the removal of water): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Mefoxin and Protonix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mefoxin and Protonix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mefoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Protonix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mefoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Protonix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefoxitin sodium and pantoprazole sodium (the active ingredients of Mefoxin and Protonix, respectively), and Mefoxin and Protonix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: